🇺🇸 FDA
Patent

US 6747034

CRF receptor antagonists and methods relating thereto

expired A61PA61P1/00A61P25/00

Quick answer

US patent 6747034 (CRF receptor antagonists and methods relating thereto) held by Neurocrine Biosciences, Inc. expires Mon Jun 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Neurocrine Biosciences, Inc.
Grant date
Tue Jun 08 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
31
CPC classes
A61P, A61P1/00, A61P25/00, A61P25/22, A61P25/24